Efficacy of a fixed combination of ciclesonide and formoterol: The EXCITED-study (Q84886392)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890335 AND SRC:MED&resulttype=core&format=json

12 February 2020

title

Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890335 AND SRC:MED&resulttype=core&format=json

12 February 2020

Efficacy of a fixed combination of ciclesonide and formoterol: The EXCITED-study (English)

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

11 December 2024

2

Roland Buhl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890335 AND SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Stephanie Korn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890335 AND SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21890335

11 December 2024

publication date

3 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890335 AND SRC:MED&resulttype=core&format=json

full work available at URL

12 February 2020

http://www.resmedjournal.com/article/S0954611111002873/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21890335

https://api.elsevier.com/content/article/PII:S0954611111002873?httpAccept=text/xml

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

https://api.elsevier.com/content/article/PII:S0954611111002873?httpAccept=text/plain

11 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

11 December 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890335 AND SRC:MED&resulttype=core&format=json

12 February 2020

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890335 AND SRC:MED&resulttype=core&format=json

12 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890335 AND SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

57-67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890335 AND SRC:MED&resulttype=core&format=json

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

12 February 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

11 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma

11 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids

11 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma

11 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patien

11 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group

11 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma

11 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma

11 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

11 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Comparison of the Relative Efficacy of Formoterol and Salmeterol in Asthmatic Patients

11 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma

11 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action

11 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies

11 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Adherence to asthma controller medication regimens

11 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

11 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma

11 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma.

11 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma.

11 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma

11 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma

11 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma

11 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma

11 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Formoterol in clinical practice--safety issues

11 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Standardization of Spirometry, 1994 Update. American Thoracic Society

11 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

11 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Practical issues in equivalence trials.

11 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma

11 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma

11 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations.

11 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

11 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Combination therapy in asthma--fixed or variable dosing in different patients?

11 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma

11 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatment

11 December 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma

11 December 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma

11 December 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study

11 December 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study

11 December 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

The use of beta-agonists and the risk of death and near death from asthma

11 December 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Bronchodilator treatment and deaths from asthma: case-control study.

11 December 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Evaluating safety of long-acting beta agonists (LABAs) in patients with asthma.

11 December 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

FDA LABA warning: is there anything new here?

11 December 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

The addition of long-acting beta-agonists to inhaled corticosteroids in asthma

11 December 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone

11 December 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma

11 December 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients

11 December 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.RMED.2011.08.010

11 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890335 AND SRC:MED&resulttype=core&format=json

12 February 2020

1 reference